Cited by 703Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Open access

Perrin, Richard J., Fagan, Anne M., Holtzman, David M.·2009·Nature

DOI 10.1038/nature08538PMC PMC2810658

Open this paper in CoChat — free account

Abstract

Alzheimer's disease affects millions of people around the world. Currently, there are no treatments that prevent or slow the disease. Like other neurodegenerative diseases, Alzheimer's disease is characterized by protein misfolding in the brain. This process and the associated brain damage begin years before the substantial neurodegeneration that accompanies dementia. Studies using new neuroimaging techniques and fluid biomarkers suggest that Alzheimer's disease pathology can be detected preclinically. These advances should allow the design of new clinical trials and early mechanism-based therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08538

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Searching for a baseline: Functional imaging and the resting human brain
Gusnard, D. A., & Raichle, M. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094500 · Cited by 3,371
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Flagged first, then by citations

Show all 83 references

Research works printed but not linked: 3

Alzheimer, A. About a peculiar disease of the cerebral cortex [translation]. Alzheimer Dis. Assoc. Disord. 1, 7–8 (1987).
Morris J. C. et al. PIB imaging predicts progression to symptomatic Alzheimer's disease. Arch. Neurol. (in the press).
Cairns, N. J. et al. PiB-PET detection of cerebral Aβ may lag clinical, cognitive, and CSF markers of Alzheimer's disease: a case report. Arch. Neurol. (in the press).

Sorted by citations

Items 401–500 of 703

The potential roles of genetic factors in predicting ageing-related cognitive change and Alzheimer’s disease
Pan, G., King, A. E., Wu, F., Simpson, S., Woodhouse, A., Phipps, A., & Vickers, J. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101402 · Cited by 19
Cerebrospinal fluid biomarkers of Alzheimer’s disease
Sui, X., Liu, J., & Yang, X. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1412-1 · Cited by 17
The effect of an APOE polymorphism on cognitive function depends on age
Shin, M., Kweon, S., Choi, J., Lee, Y. H., Nam, H., Park, K.-S., Kim, H. N., Song, H., Kim, B. C., Choi, S., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7157-y · Cited by 18
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo
Klein, R. M., Blaschke, S. J., Neumaier, B., Endepols, H., Graf, R., Keuters, M. H., Hucklenbroich, J., Albrechtsen, M., Rees, S., Fink, G. R., et al. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9512-5 · Cited by 16
Mitochondrial depletion in CD4 + and CD19 + peripheral lymphocytes in early stage Alzheimer’s disease
Terzioğlu, G., Örmeci, B., Türksoy, Ö., Sayman, C., Çınar, N., Öztürk, G. A., & Demirel, G. Y. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.09.003 · Cited by 16
Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons
Rodriguez, L., Mdzomba, J. B., Joly, S., Boudreau-Laprise, M., Planel, E., & Pernet, V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00293 · Cited by 16
One-pot green synthesis of I@CNDs-Fe3O4 hybrid nanoparticles from kelp for multi-modal imaging in vivo
Li, W., Zeng, G., Yan, J., Liu, X., Jiang, X., Yang, J., Liu, J., & Sun, D. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112037 · Cited by 16
2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators for 64 Cu PET imaging in Alzheimer's disease
Wang, Y., Huynh, T. T., Bandara, N., Cho, H., Rogers, B. E., & Mirica, L. M. (2021) · Dalton Transactions · doi:10.1039/d1dt02767k · Cited by 16
Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles
Huang, F., Wang, J., Qu, A., Shen, L., Liu, J., Liu, J., Zhang, Z., An, Y., & Shi, L. (2014) · Angewandte Chemie · doi:10.1002/ange.201400735 · Cited by 16
Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective
Frasier, M. A., Chowdhury, S., Eberling, J. L., & Sherer, T. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.89 · Cited by 16
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease
Dumurgier, J., Gabelle, A., Vercruysse, O., Bombois, S., Laplanche, J., Peoc’h, K., Schraen‐Maschke, S., Sablonnière, B., Pasquier, F., Touchon, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.023 · Cited by 17
Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging
Liu, S., Cai, W., Pujol, S., Kikinis, R., & Feng, D. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00023 · Cited by 17
Divalent 2-(4-Hydroxyphenyl)benzothiazole Bifunctional Chelators for 64 Cu Positron Emission Tomography Imaging in Alzheimer’s Disease
Terpstra, K., Wang, Y., Huynh, T. T., Bandara, N., Cho, H., Rogers, B. E., & Mirica, L. M. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c02740 · Cited by 16
A multimodal fusion method for Alzheimer’s disease based on DCT convolutional sparse representation
Zhang, G., Nie, X., Liu, B., Yuan, H., Li, J., Sun, W., & Huang, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1100812 · Cited by 15
A Cyclic Undecamer Peptide Mimics a Turn in Folded Alzheimer Amyloid β and Elicits Antibodies against Oligomeric and Fibrillar Amyloid and Plaques
Hoogerhout, P., Kamphuis, W., Brugghe, H. F., Sluijs, J. A., Timmermans, H., Westdijk, J., Zomer, G., Boog, C. J. P., Hol, E. M., & van den Dobbelsteen, G. P. J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019110 · Cited by 15
Elevated Aβ42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis
Sadleir, K. R., Bennett, D. A., Schneider, J. A., & Vassar, R. J. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990152 · Cited by 15
A reaction–diffusion model of spatial propagation of A$$\beta $$ oligomers in early stage Alzheimer’s disease
Andrade‐Restrepo, M., Ciuperca, I. S., Lemarre, P., Pujo-Menjouet, L., & Tine, L. M. (2021) · Journal of Mathematical Biology · doi:10.1007/s00285-021-01593-3 · Cited by 15
Neutral Ligands as Potential 64 Cu Chelators for Positron Emission Tomography Imaging Applications in Alzheimer’s Disease
Huang, Y., Huynh, T. T., Sun, L., Hu, C., Wang, Y.-C., Rogers, B. E., & Mirica, L. M. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00621 · Cited by 15
Phytochemical Screening, Atomic Absorption Spectroscopy, GC-MS and Antibacterial Activities of Turmeric (Curcuma longa L.) Rhizome Extracts
Momoh, J. O., Manuwa, A. A., & Bankole, Y. O. (2022) · Journal of Advances in Microbiology · doi:10.9734/jamb/2022/v22i930498 · Cited by 15
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 14
Self-citation
Detecting Shared Genetic Architecture Among Multiple Phenotypes by Hierarchical Clustering of Gene-Level Association Statistics
McGuirl, M. R., Smith, S. P., Sandstede, B., & Ramachandran, S. (2020) · Genetics · doi:10.1534/genetics.120.303096 · Cited by 15
A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer’s Disease
Tabarestani, S., Eslami, M., Cabrerizo, M., Curiel, R. E., Barreto, A. B., Rishe, N. D., Vaillancourt, D. E., DeKosky, S. T., Loewenstein, D., Duara, R., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.810873 · Cited by 14
Effects of creatine in a rat intestinal model of ischemia/reperfusion injury
Orsenigo, M., Porta, C., Sironi, C., Laforenza, U., Meyer, G., & Tosco, M. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0222-3 · Cited by 14
Is it possible to extract a fingerprint for early breast cancer via EEG analysis?
Poulos, M., Felekis, T., & Evangelou, A. M. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.016 · Cited by 14
ACR–ASNR Practice Parameter for Brain PET/CT Imaging Dementia
Frey, K. A., Lodge, M. A., MELTZER, C. C., Peller, P. J., Wong, T. Z., Hess, C. P., Petrella, J. R., Sair, H. I., & Subramaniam, R. M. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001037 · Cited by 14
Alzheimer disease: current concepts & future directions.
Musiek, E. S., & Schindler, S. E. (2013) · Europe PMC (PubMed Central) · Cited by 14
Diagnostic methods and biomarkers for Alzheimer’s disease
Bagyinszky, E., Youn, Y. C., An, S. S. A., & Kim, S. (2014) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-014-0198-5 · Cited by 13
Extracellular Zn2+-Dependent Amyloid-β1–42 Neurotoxicity in Alzheimer’s Disease Pathogenesis
Sato, Y., Takiguchi, M., Tamano, H., & Takeda, A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02131-w · Cited by 14
Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons
Yamamoto, K., Yamamoto, R., & Kato, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.660319 · Cited by 13
Monitoring Alzheimer’s Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods
Beheshti, I., Initiative, A. D. N., Geddert, N., Perron, J., Gupta, V., Albensi, B. C., & Ko, J. H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220585 · Cited by 13
Immunoprecipitation of Amyloid Fibrils by the Use of an Antibody that Recognizes a Generic Epitope Common to Amyloid Fibrils
Greiner, E. R., Kelly, J. W., & Palhano, F. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105433 · Cited by 13
Neuroinflammation and Proteostasis are Modulated by Endogenously Biosynthesized Neuroprotectin D1
Bazan, N. G. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8322-5 · Cited by 13
Altered immune response is associated with sex difference in vulnerability to Alzheimer's disease in human prefrontal cortex
Wen, H., He, Y., Tang, Y., Zhu, L., Tao, Q., Jin, B., Luo, T., Peng, Y., Wei, Y., Lei, J., et al. (2024) · Brain Pathology · doi:10.1111/bpa.13318 · Cited by 13
Construction of an “aptamer-target-peptide” Sandwich Electrochemical Biosensor for Ultrasensitive Assay of Amyloid-Beta Oligomers based on Bimetallic Covalent Organic Framework
Lv, Y., Zhou, Y., Lv, C., Wang, M., Sheng, N., Lin, Y., Wang, C., Xu, M., Zhang, J., & Yan, M. (2025) · Journal of Analysis and Testing · doi:10.1007/s41664-025-00382-x · Cited by 12
Will Posttranslational Modifications of Brain Proteins Provide Novel Serological Markers for Dementias?
Wang, Y., Sørensen, M. G., Zheng, Q., Zhang, C., Karsdal, M. A., & Henriksen, K. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/209409 · Cited by 13
A Minimally-Invasive Method for Serial Cerebrospinal Fluid Collection and Injection in Rodents with High Survival Rates
Han, J. R., Yang, Y., Wu, T. W., Shi, T.-T., Li, W., & Zou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11061609 · Cited by 12
Failure to stop autocorrect errors in reading aloud increases in aging especially with a positive biomarker for Alzheimer’s disease.
Gollan, T. H., Smirnov, D. S., Salmon, D. P., & Galasko, D. (2020) · Psychology and Aging · doi:10.1037/pag0000550 · Cited by 13
Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline
Espenes, R., Kirsebom, B., Eriksson, C. M., Waterloo, K. K., Hessen, E., Johnsen, S. H., Selnes, P., & Fladby, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190712 · Cited by 13
Preclinical PET and SPECT Imaging in Small Animals: Technologies, Challenges and Translational Impact
Bruzgo-Grzybko, M., Kalita, I. S., Olichwier, A. J., Bielicka, N., Chabielska, E., & Gromotowicz‐Poplawska, A. (2025) · Cells · doi:10.3390/cells15010073 · Cited by 12
mBGT: Encoding Brain Signals With Multimodal Brain Graph Transformer
Peng, C., Guo, T., Xie, C., Bai, X., Zhou, J., Zhao, X., He, E., & Xia, F. (2024) · IEEE Transactions on Consumer Electronics · doi:10.1109/tce.2024.3425478 · Cited by 11
Vesicle trafficking and pathways to neurodegeneration
Blackstone, C. D., Elwood, F., Plun‐Favreau, H., & Lewis, P. A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00480-1 · Cited by 11
Computer-Aided Diagnosis of Alzheimer’s Disease via Deep Learning Models and Radiomics Method
Dai, Y., Bai, W., Tang, Z., Xu, Z., & Chen, W. (2021) · Applied Sciences · doi:10.3390/app11178104 · Cited by 11
The effect of EEG and fNIRS in the digital assessment and digital therapy of Alzheimer’s disease: a systematic review
Zhang, Y., Zhang, Y., Jiang, Z., Xu, M., & Qing, K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1269359 · Cited by 11
Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease
Fu, J., Lai, X., Zhang, C., Wei, Q., Chen, X., & Shang, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13841 · Cited by 11
Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress
Gozes, I. (2017) · The EPMA Journal · doi:10.1007/s13167-017-0110-x · Cited by 11
Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
Kirsebom, B., Espenes, R., Waterloo, K. K., Hessen, E., Johnsen, S. H., Bråthen, G., Aarsland, D., & Fladby, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170385 · Cited by 12
Modeling neurodegenerative diseases using non-human primates: advances and challenges
Li, B., He, D., Li, X., & Guo, X. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.14 · Cited by 11
Surface plasmon resonance sensing of a biomarker of Alzheimer disease in an intensity measurement mode with a bimetallic chip
Kim, H. J., Sohn, Y., Kim, C.-D., & Jang, D. (2016) · Journal of the Korean Physical Society · doi:10.3938/jkps.69.793 · Cited by 11
Integrating large foundation models into multimodal named entity recognition with evidential fusion
Liu, W., Zhong, X., Hou, J., Li, S., Huang, H., Zhou, W., & Fang, Y. (2025) · Neurocomputing · doi:10.1016/j.neucom.2025.131015 · Cited by 11
Elevated Plasma Levels of Drebrin in Glaucoma Patients With Neurodegeneration
Gan, Y.-J., Fang, A., Liu, C., Liu, B.-J., Yang, F., Guan, J.-T., Lan, C., Dai, X., Li, T., Cao, Y., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00326 · Cited by 10
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment
Kim, S. J., Woo, S., Kim, Y. J., Jang, H., Kim, H. J., Na, D. L., Kim, S., & Seo, S. W. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.012 · Cited by 11
Treatment of Alzheimer's disease by microcapsule regulates neurotransmitter release via microfluidic technology
Yao, W., Che, J., Zhao, C., Zhang, X., Zhou, H., & Bai, F. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.02.005 · Cited by 10
ZCCHC17 Modulates Neuronal RNA Splicing and Supports Cognitive Resilience in Alzheimer's Disease
Bartosch, A. M. W., Youth, E. H. H., Hansen, S., Wu, Y., Buchanan, H. M., Kaufman, M. E., Xiao, H., Koo, S. Y., Ashok, A., Sivakumar, S., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2324-22.2023 · Cited by 10
Aβ(42) induced MRI changes in aged rabbit brain resembles AD brain
Ramesh, B. N., Raichurkar, K. P., Shamasundar, N. M., Rao, T. S., & Rao, K. S. J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.06.003 · Cited by 10
Effects of an Interdisciplinary Care Team on the Management of Alzheimer's Disease in China
Chen, C., Huang, Y., Liu, C., Xu, Y. H., Zheng, L., & Li, J. (2019) · Journal of Gerontological Nursing · doi:10.3928/00989134-20190318-01 · Cited by 10
Sleep in Normal Aging, Alzheimer's Disease, and Mild Cognitive Impairment
Gagnon, J., Lafrenière, A., Rauchs, G., Petit, D., & Carrier, J. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-813743-7.00045-1 · Cited by 13
Nanotheranostics: The Future Remedy of Neurological Disorders
Sohail, S., & Fakhar-ud-Din (2021) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-76263-6_5 · Cited by 10
Ultrasensitive Detection of Biomarkers in a Color‐Switchable Microcavity‐Reactor Laser
Li, R., Song, Z., Zhu, H., Zhang, F., Chen, L., Ning, C., & Ruan, S. (2022) · Advanced Science · doi:10.1002/advs.202202326 · Cited by 10
In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy
Wu, M., Schweitzer, N., Iordanova, B. E., Halligan‐Eddy, E., Tudorascu, D., Mathis, C. A., Lopresti, B. J., Kamboh, M. I., Cohen, A. D., Snitz, B. E., et al. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.09.011 · Cited by 10
Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models
Statsenko, Y. A., Meribout, S., Habuza, T., Almansoori, T. M., Gorkom, K., Gelovani, J. G., & Ljubisavljević, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.943566 · Cited by 10
Extracellular Zn2+-independently attenuated LTP by human amyloid β1-40 and rat amyloid β1-42
Tamano, H., Takiguchi, M., Shimaya, R., Adlard, P. A., Bush, A. I., & Takeda, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.037 · Cited by 10
Tyrosine kinase as therapeutic target of neurodegenerative disorders
Karati, D., & Kumar, D. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100193 · Cited by 10
Discerning Mild Cognitive Impairment and Alzheimer Disease from Normal Aging
Liao, W., Long, X., Jiang, C., Diao, Y., Liu, X., Zheng, H., & Zhang, L. (2014) · Academic Radiology · doi:10.1016/j.acra.2013.12.001 · Cited by 9
A Tangible Educative 3D Printed Atlas of the Rat Brain
Quiñones, D. R., Agulló, J. F., Pérez‐Feito, R., García-Manrique, J. A., Canals, S., & Moratal, D. (2018) · Materials · doi:10.3390/ma11091531 · Cited by 9
Electrochemical quantification of the Alzheimer’s disease amyloid-β (1–40) using amyloid-β fibrillization promoting peptide
Fujii, S., Sono, D., Matsubara, K., & Abe, H. (2015) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2015.09.001 · Cited by 9
Icariin upregulates phosphorylated cyclic adenosine monophosphate response element binding protein levels in the hippocampus of the senescence- accelerated mouse.
Zhang, Z., Zhang, T., & Dong, K. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.12.001 · Cited by 9
Latent Class and Transition Analysis of Alzheimer's Disease Data
Alashwal, H., Diallo, T., Tindle, R., & Moustafa, A. A. (2020) · Frontiers in Computer Science · doi:10.3389/fcomp.2020.551481 · Cited by 9
Neurobiology of Alzheimer’s Disease
Wong, P. C., Savonenko, A. V., Li, T., & Price, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00046-8 · Cited by 9
Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V
Claes, F., Rudyak, S. G., Laird, A. S., Louros, N. N., Beerten, J., Debulpaep, M., Michiels, E., van der Kant, R., Durme, J. V., Baets, G. D., et al. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaa008 · Cited by 9
Functional imaging constrained diffusion for brain PET synthesis from structural MRI
Yu, M., Wu, M., Yue, L., Bozoki, A., & Liu, M. (2026) · Medical Image Analysis · doi:10.1016/j.media.2026.104044 · Cited by 11
Toward the Identification of Neurophysiological Biomarkers for Alzheimer’s Disease in Down Syndrome: A Potential Role for Cross-Frequency Phase-Amplitude Coupling Analysis
Victorino, D. B., Faber, J., Pinheiro, D. J. L. L., Scorza, F. A., de Almeida, A.-C. G., Costa, A. C. S., & Scorza, C. A. (2022) · Aging and Disease · doi:10.14336/ad.2022.0906 · Cited by 8
Toward Prevention and Reduction of Alzheimer’s Disease
González-Madrid, A., Calfío, C., González, A., Lüttges, V., & Maccioni, R. B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230454 · Cited by 8
Abnormal motor cortical plasticity as a useful neurophysiological biomarker for Alzheimer’s disease pathology
Murakami, T., Abe, M., Tiksnadi, A., Nemoto, A., Futamura, M., Yamakuni, R., Kubo, H., Kobayashi, N., Ito, H., Hanajima, R., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.12.131 · Cited by 8
Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer
Müller, E., Enzlein, T., Niemeyer, D., von Ammon, L., Stumpo, K. A., Biber, K., Klein, C., & Hopf, C. (2025) · Pharmaceuticals · doi:10.3390/ph18020252 · Cited by 10
Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease
Ma, S. L., & LAM, L. C. W. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.54 · Cited by 8
Decreased Cognitive Function in Extended Family Members from the Single Late-Onset-Alzheimer's-Disease Pedigree
Zeng, Y., Chang, W., Shu, C., Ma, L., Huang, Y., Wang, R., Zhang, J., Zhu, C., & McClintock, S. M. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000581 · Cited by 9
Are the revised diagnostic criteria for Alzheimer's disease useful in low- and middle-income countries?
Yang, C., & Shifu, X. (2015) · Europe PMC (PubMed Central) · doi:10.11919/j.issn.1002-0829.215001 · Cited by 8
Amyloid β1–42-Induced Rapid Zn2+ Influx into Dentate Granule Cells Attenuates Maintained LTP Followed by Retrograde Amnesia
Tamano, H., Suzuki, H., Murakami, T., Fujii, H., Adlard, P. A., Bush, A. I., & Takeda, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1429-6 · Cited by 8
Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus women
Wu, M., Thurston, R. C., Tudorascu, D., Karim, H. T., Mathis, C. A., Lopresti, B. J., Kamboh, M. I., Cohen, A. D., Snitz, B. E., Klunk, W. E., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.020 · Cited by 9
A longitudinal study using latent curve models of groups with mild cognitive impairment and Alzheimer’s disease
Moustafa, A. A., Tindle, R., Alashwal, H., & Diallo, T. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.109040 · Cited by 8
Biological Markers and Alzheimer Disease: A Canadian Perspective
Schipper, H. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/978182 · Cited by 8
Introduction: Biomarkers in Translational and Personalized Medicine
Kumar, C., & van Gool, A. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734363-00003 · Cited by 6
Proteomic Markers and Early Prediction of Alzheimer’s Disease
Zakharova, N. V., Bugrova, A. E., Indeykina, M. I., Fedorova, Y. B., Колыхалов, И. В., Si, G., Николаев, Е. Н., & Kononikhin, A. S. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922080089 · Cited by 7
Deep Learning Techniques for Automated Dementia Diagnosis Using Neuroimaging Modalities: A Systematic Review
Özkan, D., KATAR, O., Ak, M., Al–antari, M. A., Ak, N. Y., Yıldırım, Ö., Mir, H., Tan, R., & Acharya, U. R. (2024) · IEEE Access · doi:10.1109/access.2024.3454709 · Cited by 7
Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
Chen, Y., Li, M., Zheng, Y., & Li, Y. (2019) · Journal of Visualized Experiments · doi:10.3791/59310 · Cited by 7
Is it possible to identify individuals with mild cognitive impairment and Alzheimer's disease using a 30-minute neuropsychological battery?
Coutinho, G., de Oliveira‐Souza, R., Moll, J., Tovar-Moll, F. F., & Mattos, P. (2013) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832013000400003 · Cited by 7
Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders
Sandoval-Hernández, A. G., Contreras-Zarate, M. J., Jaramillo, J., & Arboleda, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_14 · Cited by 7
Association between Malnutrition and Cognitive Impairment among Morocco’s Older Adults
Talhaoui, A., Aboussaleh, Y., Ahami, A. O. T., Sbaibi, R., & Agoutim, N. (2019) · Open Journal of Medical Psychology · doi:10.4236/ojmp.2019.81001 · Cited by 7
Effects of Physical Activity on Brain Energy Biomarkers in Alzheimer’s Diseases
Ebrahimi, K., Jourkesh, M., Sadigh‐Eteghad, S., Stannard, S. R., Earnest, C. P., Ramsbottom, R., António, J., & Navin, K. H. (2020) · Diseases · doi:10.3390/diseases8020018 · Cited by 8
Association of Performance on the Financial Capacity Instrument–Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults
Vassilaki, M. E., Aakre, J. A., Kremers, W. K., Mielke, M. M., Geda, Y. E., Machulda, M. M., Knopman, D. S., Vemuri, P., Lowe, V. J., Jack, C. R., et al. (2022) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001157 · Cited by 7
The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer’s Disease
Katsipis, G., Tzekaki, E. E., Iasonidou, S., & Pantazaki, Α. A. (2025) · Cells · doi:10.3390/cells14181424 · Cited by 6
Evaluation of a fully automated assay for the measurement of plasma pTau217 and a composite score integrating the ratio Aβ1-42/1-40 as biomarkers of Alzheimer’s disease
Morgado, B., Klafki, H., Bauer, C., Steiert, A., Waniek, K., Lachmann, I., Osterloh, D., Esselmann, H., Hansen, N., Schuchhardt, J., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02123-8 · Cited by 6
UAMRL: multi-granularity uncertainty-aware multimodal representation learning for drug-target affinity prediction
Xu, W., Liu, X., Wang, J., Zhang, F., Hu, D., & Zong, L. (2025) · Bioinformatics · doi:10.1093/bioinformatics/btaf512 · Cited by 6
Machine learning based on event-related oscillations of working memory differentiates between preclinical Alzheimer’s disease and normal aging
Liao, K., Martin, L. E., Fakorede, S., Brooks, W. M., Burns, J. M., & Devos, H. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.11.013 · Cited by 6
NBD-BPEA regulates Zn2+- or Cu2+-induced Aβ40 aggregation and cytotoxicity
Chen, T., Zhang, Y., Shang, Y., Gu, X., Zhu, Y. P., & Zhu, L. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.03.035 · Cited by 6
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
Yadav, A. K., & Mazahir, F. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220420133059 · Cited by 6
MRI and CSF biomarkers in AD—accuracy and temporal change
Prins, N. D., & Swieten, J. C. V. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.173 · Cited by 6
Difference in ability for extracellular Zn2+ influx between human and rat amyloid β1-42 and its significance
Tamano, H., Suzuki, H., Kobuchi, S., Adlard, P. A., Bush, A. I., & Takeda, A. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.01.005 · Cited by 6
Evaluación de la enfermedad de Alzheimer en etapa temprana: biomarcadores y pruebas neuropsicológicas
Lanfranco, R. C., Manríquez-Navarro, P., Leyla Avello, G., & Canales‐Johnson, A. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012000900014 · Cited by 13
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ
Agholme, L., Clarin, M., Gkanatsiou, E., Kettunen, P., Chebli, J., Brinkmalm, G., Blennow, K., Bergström, P., Portelius, E., & Zetterberg, H. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.10.009 · Cited by 6

Authors: Perrin, R. J., Fagan, A. M., & Holtzman, D. M.
Affiliations: Washington University in St. Louis (US)
ORCID: Perrin, Richard J.
Fagan, Anne M.
Holtzman, David M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-10
Volume: 461
Issue: 7266
Pages: 916-922
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08538
PMC: PMC2810658
OpenAlex: W2085558649
Cited by: 702
References: 83
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 28 · 2022: 43 · 2021: 56 · 2020: 38 · 2019: 38 · 2018: 36 · 2017: 48 · 2016: 33 · 2015: 49 · 2014: 53 · 2013: 58 · 2012: 60
FWCI: 5.97
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health (5t32ns007205-32)
National Institute on Aging (P50AG005681, P01 AG0 3991, P01AG003991, P50AG00568125, P01AG026276)
National Institute of Neurological Disorders and Stroke (T32-NS007205)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: Alzheimer's disease, multimodal diagnosis, prognosis, neuroimaging, fluid biomarkers, preclinical detection, protein misfolding, neurodegeneration, dementia, clinical trials
MeSH terms: Alzheimer Disease, Humans, Inflammation, Prognosis, Amyloid beta-Peptides, tau Proteins, Oxidative Stress, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks